Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
Ehrenreich H, Degner D, Meller J, Brines M, Béhé M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Brück W, Rüther E, Cerami A, Becker W, Sirén AL.
Ehrenreich H, et al. Among authors: siren al.
Mol Psychiatry. 2004 Jan;9(1):42-54. doi: 10.1038/sj.mp.4001442.
Mol Psychiatry. 2004.
PMID: 14581931
Clinical Trial.